Tumor subregion and immune cell type-selective proteomic profiling
- Institution
- UNIVERSITY OF ILLINOIS AT CHICAGO, IL
- Principal investigator
- Steve Seung-Young Lee
- Funding
- $212K
- Duration
- 2024–2026
Moonbase score
Still being scored
Abstract
Project Abstract A tumor is complex ecosystem in which cancer cells interact with diverse immune cells, creating a cancer- supportive microenvironment. The locations of these immune cells within a tumor significantly affect their functions, which are associated with cancer progression, metastasis, and response to therapy. We propose to develop a novel spatial proteomics approach by integrating 3D microscopy techniques with bottom-up proteomic assays, which can offer deep proteome profiles of specific immune cells at various subregions of a tumor. In Aim 1, we will develop a workflow involving 3D photobleaching-mediated spatial fluorescence encoding of immune cells located in different subregions of a mouse tumor. In Aim 2, we will apply the spatial proteomics method to identify macrophage niches associated with therapeutic responses in the tumor microenvironment. If successful, this innovative approach will revolutionize our ability not only to understand the spatially associated functions of immune cells in tumors but also to discover new immune cell niches as biomarkers and targets for accurate diagnosis and effective therapy for cancers.
LOADING MOONBASE SCORE
Questions for UNIVERSITY OF ILLINOIS AT CHICAGO
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of Illinois at ChicagoNot yet scored
Microfluidic immunotherapy screening on a core needle biopsy
Steve Seung-Young Lee · $386K · 2025–2027
- NIH · University of Illinois at ChicagoNot yet scored
Integrated three-dimensional (3D) microscopy for a spatial pharmacology atlas of macromolecular drugs in the tissue microenvironment
Steve Seung-Young Lee · $394K · 2021–2026
- NIH · University of Illinois at Chicago47
MASLD protection by STAT5-regulated transcription factors
Rhonda D Kineman · $825K · 2025–2030